WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
46.32
-0.12 (-0.26%)
At close: 4:24PM EST
Stock chart is not supported by your current browser
Previous Close46.44
Open46.02
Bid46.30 x 0
Ask46.38 x 0
Day's Range45.45 - 47.60
52 Week Range17.16 - 76.68
Volume3,061,956
Avg. Volume6,864,678
Market Cap15.627B
Beta (3Y Monthly)2.53
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Pot companies still working out the supply kinks to meet strong Canadian demand
    MarketWatch1 hour ago

    Pot companies still working out the supply kinks to meet strong Canadian demand

    After a week of earnings reports from some of the largest cannabis producers in Canada and a month of legal marijuana, a clear picture has emerged: the shortages the country experienced on the first day of recreational legalization occurred, in large part, because the heavyweights didn’t ship very much pot.

  • 4 Prominent Marijuana Earnings Season Trends
    Motley Fool3 hours ago

    4 Prominent Marijuana Earnings Season Trends

    Surprise! Pot stock operating results actually matter now.

  • Better Buy: OrganiGram Holdings Inc. vs. Canopy Growth Corporation
    Motley Fool8 hours ago

    Better Buy: OrganiGram Holdings Inc. vs. Canopy Growth Corporation

    It's a matchup of small against big in this battle of Canadian marijuana stocks.

  • Trulieve to Announce Q3 Earnings on November 19!
    Market Realistyesterday

    Trulieve to Announce Q3 Earnings on November 19!

    Trulieve Cannabis Corp (TCNNF) is a licensed medical cannabis company set to release its Q3 2018 earnings on November 19 at 10:00 AM ET. Analysts expect Trulieve to report revenues of 35.1 million Canadian dollars for the third quarter of 2018. Trulieve is a vertically integrated cannabis company involved in the cultivation, production, and commercialization of cannabis products in the State of Florida.

  • MedMen’s Must-Know Revenue Drivers
    Market Realistyesterday

    MedMen’s Must-Know Revenue Drivers

    MedMen’s (MMNFF) reported revenues are generated from direct sales through its retail stores. The company has reported no material revenues from cultivation or production wholesale operations in the fiscal year ended June 30.

  • Why Citron’s Andrew Left Is Shorting Cannabis Stocks
    Market Realistyesterday

    Why Citron’s Andrew Left Is Shorting Cannabis Stocks

    Cannabis stocks have made several investors wary because of their high level of volatility. Earlier this week, some of the companies that reported earnings such as Canopy Growth (WEED), Tilray (TLRY), and Aurora Cannabis (ACB) (ACBFF) missed analysts’ estimates by a large margin, and the stocks got hammered. In an interview with CNBC, Andrew Left of Citron Research was largely pessimistic on the Canadian cannabis industry and expects that cannabis stocks will fall in the near term.

  • Why Canopy Growth Is Up 42% So Far in 2018
    Motley Foolyesterday

    Why Canopy Growth Is Up 42% So Far in 2018

    Some marijuana investors are disappointed despite big gains -- but they shouldn't be.

  • Jim Cramer’s Recommendations in the Cannabis Industry
    Market Realistyesterday

    Jim Cramer’s Recommendations in the Cannabis Industry

    On November 15, the widely followed host of Mad Money on CNBC, Jim Cramer, gave his opinions on the cannabis industry. Cramer pointed investors to Canopy Growth (WEED) (CGC), the Canadian cannabis (HMMJ) giant, because of its backing from Constellation Brands as a result of the latter’s $4 billion investment.

  • Which Marijuana Stock Won Earnings Week -- Aurora Cannabis, Canopy Growth, Cronos Group, or Tilray?
    Motley Foolyesterday

    Which Marijuana Stock Won Earnings Week -- Aurora Cannabis, Canopy Growth, Cronos Group, or Tilray?

    There was a flurry of earnings releases this week from leaders of the Canadian cannabis industry. Here are the winners and losers.

  • Why Canopy Growth’s Losses Widened in the Second Quarter
    Market Realist2 days ago

    Why Canopy Growth’s Losses Widened in the Second Quarter

    During the second quarter, Canopy Growth’s (WEED) (CGC) operating losses widened from ~$1 million to almost $214 million. The company reported a net loss of $330 million, which widened from losses of $1.6 million a year ago in 2017.

  • Canopy Growth’s Plans for the Recreational Market
    Market Realist2 days ago

    Canopy Growth’s Plans for the Recreational Market

    During the second quarter, Canopy Growth’s (WEED) (CGC) registered patients grew almost 34% YoY (year-over-year) to 84,400 patients from 63,000 patients. During the same period, the company’s average selling price per gram increased 24% to $9.87 from $7.99 a year ago. The company stated that the average selling prices increased due to a change in the product mix, which had higher prices. Higher priced products sold in Germany at $13.58 per gram also lifted the average selling prices YoY.

  • Key Takeaways from Canopy Growth’s Second-Quarter Earnings
    Market Realist2 days ago

    Key Takeaways from Canopy Growth’s Second-Quarter Earnings

    On November 14, Canopy Growth (WEED) (CGC) reported its second-quarter earnings, which largely disappointed the market. As a result, the stock took a beating with an 11% decline to $34.3. The company reported revenues of 23.3 million Canadian dollars, which missed analysts’ estimate of 61.7 million Canadian dollars.

  • Canopy stock slumps after earnings show no initial boost from Canada legalization
    MarketWatch2 days ago

    Canopy stock slumps after earnings show no initial boost from Canada legalization

    Canada-based pot producer Canopy Growth Corp. posted a sequential decline in quarterly revenue Wednesday, mounting losses and said it hadn’t received a material order of recreational cannabis during the quarter.

  • How Tilray Is Advancing in International Markets
    Market Realist2 days ago

    How Tilray Is Advancing in International Markets

    In its earnings call, Tilray (TLRY) stated that its Canadian entity will serve as a production hub to meet global cannabis demand and that its Portugal entity will primarily serve as a distribution hub for global markets, specifically focusing on the European Union. The company hopes to create a strong presence in Latin America with its medical cannabis products in Chile and Brazil.

  • Why Aurora Cannabis, Canopy Growth, and Tilray Sank Today
    Motley Fool3 days ago

    Why Aurora Cannabis, Canopy Growth, and Tilray Sank Today

    Disappointing quarterly results and a broader market pullback hurt the big Canadian marijuana stocks -- at least temporarily.

  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of CGC.TO earnings conference call or presentation 14-Nov-18 1:30pm GMT

    Q2 2019 Canopy Growth Corp Earnings Call

  • Why PG&E, Switch, and Canopy Growth Slumped Today
    Motley Fool3 days ago

    Why PG&E, Switch, and Canopy Growth Slumped Today

    Earnings and liability concerns hit these stocks.

  • Here's Where Marijuana Stocks May Be Headed Next Year
    Investor's Business Daily3 days ago

    Here's Where Marijuana Stocks May Be Headed Next Year

    Canada's marijuana-stocks bubble will pop or at least deflate next year, as soaring valuations hit financial realities, said Chris Walsh, founding editor of Marijuana Business Daily.

  • Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
    Investor's Business Daily3 days ago

    Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike

    Canopy Growth reported deeper losses for fiscal Q2 despite a jump in average sales prices, rounding out a busy earnings week for marijuana stocks.

  • Stocks Rise: Nasdaq Outpaces Dow Jones, Gas Prices Bolster S&P 500
    Investor's Business Daily3 days ago

    Stocks Rise: Nasdaq Outpaces Dow Jones, Gas Prices Bolster S&P 500

    Tech stocks led an early rally Wednesday as tame inflation data drove opening trade, and earnings sent Canada Goose well beyond a buy point.

  • Market Slashes Gains As Apple Stock Hits New Low
    Investor's Business Daily3 days ago

    Market Slashes Gains As Apple Stock Hits New Low

    The Dow Jones industrial average jumped 200 points early on tame inflation, but slashed gains as Apple hit new recent lows. Canada Goose flew and Tesla outperformed.

  • 3 Reasons Canopy Growth Just Posted the Biggest Loss in Its History
    Motley Fool3 days ago

    3 Reasons Canopy Growth Just Posted the Biggest Loss in Its History

    And why there's absolutely no reason for investors to worry about it.

  • WeedMD Secures Cannabis Sales License from Health Canada
    Market Realist3 days ago

    WeedMD Secures Cannabis Sales License from Health Canada

    WeedMD (WMD) is a Canada-based licensed producer of medical marijuana. On November 13, the company announced that Health Canada approved its cannabis sales license for cannabis cultivated at its greenhouse in Ontario. The below chart lists some key highlights of WeedMD’s greenhouse. According to the company’s press release, the original license, which was issued under the Access to Cannabis for Medical Purposes regulations, was migrated to the license issued under the Cannabis Act regulations.

  • Tilray on Canadian Recreational Market and Future Growth
    Market Realist3 days ago

    Tilray on Canadian Recreational Market and Future Growth

    During its 3Q earnings call, Tilray (TLRY) stated that the recreational cannabis market will play a meaningful role for the company as it ramps up supply through increased production capacity. The company updated investors that it recently signed a supply agreement with the province of Prince Edward Island and that its products are currently available in eight provinces. The company is scaling production capacity in anticipation of strong recreational demand. 

  • Bloomberg3 days ago

    Canopy Revenue Falls Amid ‘Distraction’ of Pot Legalization

    “It is the first time in our history that I’m aware of where we actually had a slowdown, but I think it was more of a distraction than a pattern,” Bruce Linton, head of the No. 2 pot producer by market value said on the company’s earnings call Wednesday. Canopy spent much of the fiscal second quarter, which ended two and a half weeks before Canada legalized recreational pot on Oct. 17, “stress-testing” the provinces’ sales systems at their request. Canopy shares were down 7.7 percent to C$46.49 at 10:38 a.m.